GSK plc files 6-K

The US FDA has approved Utebzi (tebipenem pivoxil), an oral antibiotic for complicated urinary tract infections (cUTIs) in adults, marking the first and only oral carbapenem antibiotic approved in the US. This approval is based on the PIVOT-PO trial, which demonstrated non-inferiority compared to intravenous treatment.